Healthcare
Gimv exits Eurocept homecare division
Exit has no significant impact on the net asset value of Gimv as of 31 March 2020
Pureos Bioventures leads CHF 15.2m round for Araris
Round for the biotechnology company extends the CHF 2.5m August 2019 round led by Redalpine
HTGF, Evonik exit Synoste to trade
Deal is HTGF's 11th exit during the coronavirus pandemic, and comes seven years after the VC first invested in the company
Oakley acquires WindStar Medical
Pharmaceutical company's vendor is General Atlantic-backed NuCom, a ProSiebenSat subsidiary
HTGF, Bayern Kapital exit ChromoTek to trade
VCs invested in the nanobodies developer in 2010; ChromoTek has been sold to a US-based market peer
German biotech firm Topas raises €22m in series-B round
Biotech company has raised €40m in equity financing since 2016
Ardian buys minority stake in H2 Pharma
GP invests in the company via Ardian Growth II, which closed on €230m in April 2018
Omega leads $16m round for Chord Therapeutics
Omega managing director Claudio Nessi and principal Francesco Draetta will join the company's board
Northpond, Octopus lead $30m series-A for Ori Biotech
Existing investors Amadeus Capital Partners, Delin Ventures and Kindred Capital also join the round
Novartis, Novo lead €9m series-A for Rappta Therapeutics
Round also saw participation from family office Advent Life Sciences, and Business Finland
Miura backs Terrats Medical
Producer of dental implants and abutments operates under the DESS Dental Smart Solutions brand
Kartesia carves out ADL Biopharma from Black Toro's ADL Bionatur
Deal includes a new debt tranche of €5m made available by Kartesia at closing and a capital increase of at least €10m
Sabadell Asabys et al. lead €14m series-E for MedLumics
Previous backers Andera Partners, Caixa Capital Risc and Innogest Capital also take part in the funding round
Triton's Meine Radiologie buys Diagnostikum Berlin
Acquisition of the radiology clinic chain is part of Meine Radiologie's buy-and-build strategy
Investindustrial launches €600m China-Italy Fund
CIICF intends to support the expansion and development of Italian companies across the Chinese market
CDP Venture Capital leads €15m series-C for Wise
Indaco and Eureka also take part in the round, alongside previous backers including Principia and HTGF
Aksia's COC Farmaceutici buys Tubilux
With this acquisition the GP intends to create a platform for the development and manufacturing of ophthalmic products
Eir Ventures leads seed funding round for Synklino
Startup focuses on developing therapies against viral infections
Soleus and Eir lead $64m series-D round for Galecto
Biotech company has so far raised around $160m since being founded nine years ago
CDPQ backs Colisée alongside EQT
EQT and CDPQ intend to support the company in its growth strategy in France and internationally
Phoenix-backed Sygnature acquires XenoGesis
Previously, Sygnature has acquired two in-vivo pharmacology clinical research organisations
Ampersand Capital Partners invests in GeneWerk
Pharmaceuticals-focused GP aims to support GeneWerk's growth to meet demand for its services
Apax sells Neuraxpharm to Permira
Deal values the company at more than €1.6bn and is set to generate returns for Apax of 3.5x money
Morningside leads £40.6m series-B for Immune Regulation
Morningside's Isaac Cheng will join the company's board of directors